NCT01660932已完成4 期
Vascular and Metabolic Effects of Omega-3 Fatty Acids
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 176
- 试验地点
- 1
- 主要终点
- flow-mediated dilation
研究概览
简要总结
The investigators hypothesize that omega does-dependently improves vascular and insulin resistance.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
入排标准
- 年龄范围
- 25 Years 至 80 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •hypertriglyceridemia
排除标准
- •overt liver disease, chronic renal failure, hypothyroidism, myopathy, uncontrolled diabetes (HbA1c > 9%), severe hypertension, stroke, acute coronary events, coronary revascularization within the preceding 3 months, or alcohol abuse
研究组 & 干预措施
placebo
Placebo Comparator
placebo
干预措施: placebo (Drug)
omega 1
Active Comparator
omega 1 gm
干预措施: omega (Drug)
omega 2
Active Comparator
omega 2 gm
干预措施: omega (Drug)
omega 4
Active Comparator
omega 4 gm
干预措施: omega (Drug)
结局指标
主要结局
flow-mediated dilation
时间窗: 8 weeks of treatment
次要结局
- insulin resistance(8 weeks of treatment)
研究者
Kwang Kon Koh
professor
Gachon University Gil Medical Center
研究点 (1)
Loading locations...
相似试验
撤回
不适用
Effects of Omega-3 Fatty Acid Supplementation and Physical Training on Metabolic HealthInsulin ResistanceNCT06533891University of Arizona
已完成
3 期
Omega-3 Fatty Acids and Insulin SensitivityInsulin ResistanceNCT01686568Mayo Clinic31
已完成
3 期
Omega 3 Fatty Acids in Patients With Chronic Renal DiseaseRenal Insufficiency, ChronicNCT03280615University of Chile100
已完成
不适用
Efficacy Study Regarding the Beneficial Effects of Omega-3 Fatty Acids on Cardiometabolic HealthMetabolic Syndrome XNCT02042274University of Guelph12
已完成
不适用
Cardiometabolic Benefits of Omega-3 Polyunsaturated Fatty AcidsCardiovascular DiseaseNCT03378232University of Guelph90
